Hepatitis C Virus Rna Profiles in Chronically Infected Individuals: Do They Relate to Disease Activity?Patrizia Pontisso, Giuseppe Colucci, G. Bellati et al.|Hepatology|1999Cited by 77
Pegylated interferon-alpha2b plus ribavirin: an efficacious and well-tolerated treatment regimen for patients with hepatitis C virus related histologically proven cirrhosis.Luigi Roffi, Savino Bruno, Guido Colloredo et al.|PubMed|2008Cited by 41
Pegylated Interferon-α2b plus Ribavirin: An Efficacious and well-Tolerated Treatment Regimen for Patients with Hepatitis C virus Related Histologically Proven CirrhosisLuigi Roff, Savino Bruno, Guido Colloredo et al.|Antiviral Therapy|2008Cited by 33
755 5-YEAR ENTECAVIR TREATMENT IN NUC-NAÏVE, FIELD-PRACTICE PATIENTS WITH CHRONIC HEPATITIS B SHOWED EXCELLENT VIRAL SUPPRESSION AND SAFETY PROFILE BUT NO PREVENTION OF HCC IN CIRRHOTICSPietro Lampertico, M. Colombo, R. Soffredini et al.|Journal of Hepatology|2013Cited by 24
Four years of tenofovir monotherapy for NUC naïve field practice European patients suppresses HBV replication in most patients with a favorable renal safety profile but does not prevent HCC in patients with or without cirrhosisPietro Lampertico, M. Colombo, E. Minola et al.|Digestive and Liver Disease|2014Cited by 23